Ovid Therapeutics (OVID) Net Margin (2020 - 2026)
Ovid Therapeutics (OVID) posted Net Margin of -2047.61% for Q2 2026, down 1972.93 percentage points from -74.68% a year earlier.
Powered by 
Analysis
Ovid Therapeutics (OVID) Net Margin (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Margin at Ovid Therapeutics was -2180.10%, down 1606.08 percentage points year-over-year; for FY2025, it came in at -240.13%, up 4430.01 percentage points from FY2024.
- Annual Net Margin shows a five-year change of +402.13 percentage points (FY2020 to FY2025).
- In prior years, Ovid Therapeutics' Net Margin was -4670.14% in FY2024 (+8681.64 pp), -13351.79% in FY2023 (-9747.12 pp), -3604.66% in FY2022 (-3663.61 pp) and 58.95% in FY2021 (+701.21 pp).
- Quarterly Net Margin has run from a low of -107798.33% in Q3 2022 to a high of 5042.01% in Q2 2024 over five years.
- On a year-over-year basis, Net Margin increased in three of the last seven quarters, with an average year-over-year change of +879.89 percentage points.
- The strongest year-over-year quarter for Net Margin in the past five years was Q3 2023, with a gain of 97474.48 percentage points; the weakest was Q1 2023, with a drop of 19121.90 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Ovid Therapeutics | 454.50 Mn | 86.52 Mn | - | -2,047.61% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,047.61% |
| Dec 31, 2025 | 1,349.03% |
| Sep 30, 2025 | -9,242.42% |
| Jun 30, 2025 | -74.68% |
| Mar 31, 2025 | -7,873.08% |
| Dec 31, 2024 | -12,175.00% |
| Sep 30, 2024 | -8,095.95% |
| Jun 30, 2024 | 5,042.01% |
| Mar 31, 2024 | -7,901.35% |
| Dec 31, 2023 | -10,790.14% |
| Sep 30, 2023 | -10,323.85% |
| Jun 30, 2023 | -16,544.00% |
| Mar 31, 2023 | -20,236.36% |
| Dec 31, 2022 | -24,859.09% |
| Sep 30, 2022 | -107,798.33% |
| Mar 31, 2022 | -1,114.46% |
| Mar 31, 2021 | 84.46% |
| Dec 31, 2020 | -386.27% |
| Sep 30, 2020 | -237.56% |
API Access
Ovid Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();